Total Raised
$65MInvestors Count
5Deal Terms
1Funding, Valuation & Revenue
4 Fundings
Ornim Medical has raised $65M over 4 rounds.
Ornim Medical's latest funding round was a Series C for $20M on August 3, 2016.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/3/2016 | Series C | $20M | 8 | |||
10/28/2015 | Corporate Minority | |||||
2/19/2014 | Series B - II | |||||
8/21/2012 | Series B |
Date | 8/3/2016 | 10/28/2015 | 2/19/2014 | 8/21/2012 |
|---|---|---|---|---|
Round | Series C | Corporate Minority | Series B - II | Series B |
Amount | $20M | |||
Investors | ||||
Valuation | ||||
Revenue | ||||
Sources | 8 |
Ornim Medical Deal Terms
1 Deal Term
Ornim Medical's deal structure is available for 1 funding round, including their Series B from August 21, 2012.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Ornim Medical Investors
5 Investors
Ornim Medical has 5 investors. OrbiMed invested in Ornim Medical's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/21/2012 | 8/3/2016 | 3 Series B, Series B - II (2014), Series C (2016) | Venture Capital | New York | ||
Corporate Venture | California | |||||
Venture Capital | ||||||
Corporation | China | |||||
Venture Capital | Israel |
First funding | 8/21/2012 | ||||
|---|---|---|---|---|---|
Last Funding | 8/3/2016 | ||||
Investor | |||||
Rounds | 3 Series B, Series B - II (2014), Series C (2016) | ||||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Venture Capital | Corporation | Venture Capital |
Location | New York | California | China | Israel |
Compare Ornim Medical to Competitors

ViOptix is a company in the medical technology sector that provides technology for measuring tissue oxygen saturation. The main product, T.Ox, allows for non-invasive measurement of local tissue oxygen levels, enabling assessment of tissue health. This technology is used in plastic surgery, intraoperative and postoperative monitoring, and critical care. It was founded in 1999 and is based in Newark, California.
CSA Medical develops spray cryotherapy devices for the treatment of Chronic Bronchitis in the medical device industry. Their main product, the RejuvenAir System, is an interventional liquid nitrogen spray cryotherapy system designed to deliver thermal doses to the lungs to treat Chronic Obstructive Pulmonary Disease (COPD) associated with Chronic Bronchitis. The company serves the healthcare sector, focusing on interventional pulmonary care and clinical trial research. It was founded in 1993 and is based in Lexington, Massachusetts.
Tomophase Corporation was founded with the mission of developing solutions for minimally invasive diagnostic (MID) imaging. The company is using light to guide new ways of diagnosing diseases and has conceived major ideas for an optical MID imaging system
TruTouch Technologies specializes in alcohol detection and biometric identification systems for various industries. Its products offer rapid alcohol screening and biometric verification to ensure workplace safety without the need for supervision. The company primarily serves sectors that require safety-sensitive work environments, such as energy, transportation, and warehousing. It was founded in 2005 and is based in Riverside, California.

OrSense is a medical device company specializing in non-invasive monitoring systems within the healthcare sector. Their main offerings include devices that measure hemoglobin, oxygen saturation, and pulse rate without the need for invasive procedures, utilizing proprietary occlusion spectroscopy technology. OrSense primarily serves the healthcare industry, with a focus on blood donation facilities and medical professionals in need of non-invasive testing solutions. It is based in Israel.

AxioMed develops spinal disc replacement technologies within the medical device industry. The company's offerings include viscoelastic spinal disc replacements designed to restore spine motion and function for patients with degenerative disc disease. The products are designed to replicate the human disc. It was founded in 2001 and is based in Malden, Massachusetts. AxioMed operates as a subsidiary of KICVentures.
Loading...


